Lumi Thera Inc.: Two Year Benefits in Clinical and Anatomical Measures in Intermediate Dry AMD Patients Treated With the Valeda Light Delivery System
Location: 111
Date & Time: Saturday, 21 September, 10:15 - 11:15 CEST
Chairperson(s): M. Munk, SWITZERLAND
Speakers:
Presentations:
M. Munk SWITZERLAND
10:15 Welcome & Introduction
M. Munk SWITZERLAND
10:20 The Science Behind Photobiomodulation Treatment in Dry AMD
M. Munk SWITZERLAND
10:25 LIGHTSITE III 24-Month Clinical Trial Outcomes
G. Jaffe USA
10:35 LIGHTSITE III Anatomical Outcomes and LIGHTSITE IIIB Extension Trial Update
Ø. Utheim NORWAY
10:45 EUROLIGHT Study Update and Real World Patient
M. Munk SWITZERLAND
10:55 Q&A Discussion
This is a promotional symposium for HCPs only. Presentations and materials disclosed during the event are subject to Intellectual Property Rights. Total or partial reproduction or use of this content requires prior AbbVie authorization. Furthermore, in order to comply with the regulations regarding the promotion of medicines, we ask you not to share its contents on your social networks. Please do not distribute in media, or communication channels aimed at the general public.